Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy

2018 ◽  
Vol 17 (5) ◽  
pp. 675-687 ◽  
Author(s):  
Yu-Ting Yeh ◽  
Jui-Hui Peng ◽  
Hsien-Li Peter Peng
2021 ◽  
Author(s):  
Sun Hye Shin ◽  
Su Jung Park ◽  
Seung Hoon Yeoum ◽  
Choon Shik Youn ◽  
Kui Young Park

2009 ◽  
Vol 2 (2) ◽  
pp. 95-97 ◽  
Author(s):  
Jin-Hyuck Kim ◽  
Seok-Won Han ◽  
Yun Joong Kim ◽  
Jooyong Kim ◽  
Mi-Suh Oh ◽  
...  

2015 ◽  
Vol 48 (02) ◽  
pp. 196-199 ◽  
Author(s):  
Kasturi Bhattacharjee ◽  
Manpreet Singh ◽  
Harsha Bhattacharjee

ABSTRACTFacial asymmetry can either be physiological or pathological and is a common cosmetic concern. A 35-year-old Indian male presented with broad appearing lower face and prominent left jaw since adolescence. Parotid enlargement and other local disorders were ruled out. Ultrasonographic thickness of right masseter muscle was 13 mm while that of left was 14.9 mm, in unclenched state. Type-A botulinum toxin (T-ABT) was injected, evenly at five points, in both muscles within the “safe zone”. Using a 29 gauge needle, 15 and 25 international units were delivered to right and left masseters, respectively. Six months post — injection, a reduction of 2.9 mm and 4.4 mm was observed along with a reduced external facial asymmetry. At 24 months, patient maintains a satisfactory facial contour with no significant early or late post-injection complications. Intra-massteric injection of T-ABT can be used effectively as a primary or adjunct procedure for holistic oculo-facial sculpting.


2021 ◽  
Vol 14 (1) ◽  
pp. e239056
Author(s):  
Kumar Nilesh ◽  
Ravina Dharamsi ◽  
Pankaj Patil ◽  
Payal Mate

Masseter hypertrophy (MH) is an uncommon disorder which can cause both aesthetic and functional problems. The most common aetiological factors associated with MH are habit of chewing gum, clenching and/or bruxism. The treatment of MH includes conservative management as well as surgical resection of the enlarged muscle and/or bone. Injection of botulinum toxin type A is a relatively new and minimally invasive method for management of masseter muscle hypertrophy, which offers many advantages over conventional surgical management. This paper reports a case of unilateral MH of unknown origin which was treated with injection of botulinum toxin type A, resulting in satisfactory reduction in the volume of muscle and improvement of facial aesthetics.


CRANIO® ◽  
2009 ◽  
Vol 27 (3) ◽  
pp. 200-210 ◽  
Author(s):  
Redento Peretta ◽  
Marco Melison ◽  
Roberto Meneghello ◽  
Daniele Comelli ◽  
Luca Guarda ◽  
...  

2005 ◽  
Vol 63 (1) ◽  
pp. 20-24 ◽  
Author(s):  
Wagner Henriques Castro ◽  
Rodrigo Santiago Gomez ◽  
Jacqueline da Silva Oliveira ◽  
Mariela Dutra Gontijo Moura ◽  
Ricardo Santiago Gomez

Sign in / Sign up

Export Citation Format

Share Document